Learning objectives: Recognize important type 2 diabetes trials published in the last 3 years regarding SGLT2 inhibitors, GLP-1 receptor agonists and insulin.
Incorporate these findings into a clinical pathways in type 2 diabetes management.
Session date:
05/08/2018 - 12:00pm to 1:00pm CDT
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
John B. Buse, MD, PhD